Search research articles
Contact Us
Filters
Showing results (61-70 of 773) with videos related to
Page
of 78
Sort By:
Mayo Clinic Proceedings
|
October 6, 2012
The high cost of cancer drugs and what we can do about it
Mustaqeem Siddiqui, S Vincent Rajkumar
Leukemia
|
July 14, 2025
Solitary but not simple─a call for precision risk stratification and individualized treatment in solitary plasmacytoma
Saurabh Zanwar, S Vincent Rajkumar
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 1, 2023
Defining Myeloma and Advancing Treatment Options: A Conversation Between S. Vincent Rajkumar and Lale Kostakoglu
S Vincent Rajkumar, Lale Kostakoglu
Blood
|
September 10, 2008
Many facets of bortezomib resistance/susceptibility
Shaji Kumar, S Vincent Rajkumar
Clinical Lymphoma & Myeloma
|
October 16, 2008
Consolidation therapy with bortezomib/lenalidomide/ dexamethasone versus bortezomib/dexamethasone after a dexamethasone-based induction regimen in patients with multiple myeloma: a randomized phase III trial
Rafael Fonseca, S Vincent Rajkumar
Mayo Clinic Proceedings
|
July 6, 2020
Leaks of Clinical Trial Data and Research Integrity
S Vincent Rajkumar, Priya Sampathkumar
Blood Cancer Journal
|
March 29, 2023
Multiple myeloma with acute light chain cast nephropathy
Nelson Leung, S Vincent Rajkumar
Leukemia Research
|
March 21, 2012
"Should all eligible patients with multiple myeloma receive autologous stem-cell transplant as part of initial treatment?"
Philippe Moreau, S Vincent Rajkumar
Nature Reviews. Clinical Oncology
|
October 15, 2014
Decade in review-haematological cancer: advances in biology and therapy
S Vincent Rajkumar, Philippe Moreau
Clinical Hematology International
|
May 31, 2024
Considerations for the treatment of frail multiple myeloma patients
Mohamad Mohty, S Vincent Rajkumar
Page
of 78
Search research articles
Search
Showing results (61-70 of 773) with videos related to
Sort By:
Page
of 78
Mayo Clinic Proceedings
|
October 6, 2012
The high cost of cancer drugs and what we can do about it
Mustaqeem Siddiqui, S Vincent Rajkumar
Leukemia
|
July 14, 2025
Solitary but not simple─a call for precision risk stratification and individualized treatment in solitary plasmacytoma
Saurabh Zanwar, S Vincent Rajkumar
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 1, 2023
Defining Myeloma and Advancing Treatment Options: A Conversation Between S. Vincent Rajkumar and Lale Kostakoglu
S Vincent Rajkumar, Lale Kostakoglu
Blood
|
September 10, 2008
Many facets of bortezomib resistance/susceptibility
Shaji Kumar, S Vincent Rajkumar
Clinical Lymphoma & Myeloma
|
October 16, 2008
Consolidation therapy with bortezomib/lenalidomide/ dexamethasone versus bortezomib/dexamethasone after a dexamethasone-based induction regimen in patients with multiple myeloma: a randomized phase III trial
Rafael Fonseca, S Vincent Rajkumar
Mayo Clinic Proceedings
|
July 6, 2020
Leaks of Clinical Trial Data and Research Integrity
S Vincent Rajkumar, Priya Sampathkumar
Blood Cancer Journal
|
March 29, 2023
Multiple myeloma with acute light chain cast nephropathy
Nelson Leung, S Vincent Rajkumar
Leukemia Research
|
March 21, 2012
"Should all eligible patients with multiple myeloma receive autologous stem-cell transplant as part of initial treatment?"
Philippe Moreau, S Vincent Rajkumar
Nature Reviews. Clinical Oncology
|
October 15, 2014
Decade in review-haematological cancer: advances in biology and therapy
S Vincent Rajkumar, Philippe Moreau
Clinical Hematology International
|
May 31, 2024
Considerations for the treatment of frail multiple myeloma patients
Mohamad Mohty, S Vincent Rajkumar
Page
of 78